The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Graphene in therapeutics delivery: Problems, solutions and future opportunities
Open accessAbstract
Graphene based nanomaterials are being used experimentally to deliver therapeutic agents to cells or tissues both in vitro and in vivo. However, substantial challenges remain before moving to safe and effective use in humans. In particular, it is recognised that graphene molecules undergo complex interactions with solutes, proteins or cellular systems within the body, and that these interactions impact significantly on the behaviour or toxicity of the molecule. Approaches to overcome these problems include modification of the graphene or its combination with other molecules to accentuate favourable characteristics or modify adverse interactions. This has led to an emerging role for graphene as one part of highly-tailored multifunctional delivery vehicles. This review examines the knowledge that underpins present approaches to exploit graphene in therapeutics delivery, discussing both favourable and unfavourable aspects of graphene behaviour in biological systems and how these may be modified; then considers the present place of the molecule and the challenges for its further development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemistry of graphene oxide
Dreyer, D. R., Park, S., Bielawski, C. W., & Ruoff, R. S. (2010) · Chem. Soc. Rev. · doi:10.1039/b917103g · Cited by 11,653
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Brown, D. M., Kinloch, I. A., Bangert, U., Windle, A. H., Walter, D. M., Walker, G. S., Scotchford, C. A., Donaldson, K., & Stone, V. (2007) · Carbon · doi:10.1016/j.carbon.2007.05.011 · Cited by 271
Cited by
Promises, facts and challenges for graphene in biomedical applications
Reina, G., González-Domínguez, J. M., Criado, A., Vázquez, E., Bianco, A., & Prato, M. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00363c · Cited by 725
Dasari Shareena, T. P., McShan, D., Dasmahapatra, A. K., & Tchounwou, P. B. (2018) · Nano-Micro Letters · doi:10.1007/s40820-018-0206-4 · Cited by 414
An overview of proton exchange membranes for fuel cells: Materials and manufacturing
Ahmad, S., Nawaz, T., Ali, A., Orhan, M. F., Samreen, A., & Kannan, A. M. (2022) · International Journal of Hydrogen Energy · doi:10.1016/j.ijhydene.2022.04.099 · Cited by 336
Graphene‐Based Smart Platforms for Combined Cancer Therapy
Gu, Z., Zhu, S., Yan, L., Zhao, F., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201800662 · Cited by 334
Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy
Liu, J., Dong, J., Zhang, T., & Peng, Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.034 · Cited by 271
Metadata
- Authors
- McCallion, C., Burthem, J., Rees-Unwin, K., Golovanov, A., & Pluen, A.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 104
- Pages
- 235-250
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2339509631
- Cited by
- 241
- References
- 3
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Graphene in therapeutics delivery: Problems, solutions and future opportunities. https://app.cochat.ai/papers/10.1016/j.ejpb.2016.04.015
- The paper
- McCallion, C., Burthem, J., Rees-Unwin, K., Golovanov, A., & Pluen, A. (2016). Graphene in therapeutics delivery: Problems, solutions and future opportunities. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2016.04.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.